Hemoadsorption treatment with CytoSorb ® in patients with extracorporeal life support therapy: A case series.

CONCLUSION: Hemoadsorption may offer a potentially promising therapeutic option for critically ill patients undergoing extracorporeal life support therapy, with cytokine reduction and a consecutively mitigated inflammatory response, decreased vasoplegia, and improved organ function as seen in our patients.
PMID: 31868089 [PubMed - as supplied by publisher]

Source: The International Journal of Artificial Organs - December 22, 2019 Category: Transplant Surgery Authors: Träger K, Skrabal C, Fischer G, Schroeder J, Marenski L, Liebold A, Reinelt H, Datzmann T Tags: Int J Artif Organs Source Type: research